Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
15
Number of overlapping holdings
40.5%
% of IHE's 38 holdings also in FTXH
30.0%
% of FTXH's 51 holdings also in IHE
Overlap by Weight
Sector Drift (IHE minus FTXH)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IHE |
Weight in FTXH |
Overlap | |
|---|---|---|---|---|
 |
JOHNSON & JOHNSON | 22.8% | 7.5% | 7.5% |
|
BRISTOL-MYERS SQUIBB CO | 4.6% | 7.6% | 4.6% |
|
PFIZER INC | 4.5% | 7.2% | 4.5% |
|
MERCK & CO. INC. | 4.3% | 7.3% | 4.3% |
|
ZOETIS INC | 4.6% | 3.7% | 3.7% |
Position Highlights (Non-Overlapping Exposures)
IHE Overweight Relative to FTXH
|
ELI LILLY & CO | 19.4% |
|
JOHNSON & JOHNSON | 15.4% |
|
INTRA-CELLULAR THERAPIES INC | 4.6% |
|
ROYALTY PHARMA PLC CLASS A | 4.3% |
|
CORCEPT THERAPEUTICS INC | 1.7% |
|
AXSOME THERAPEUTICS, INC. | 1.5% |
|
PRESTIGE BRANDS HOLDINGS INC | 1.0% |
|
ZOETIS INC | 0.9% |
|
LIGAND PHARMACEUTICALS-CL B | 0.8% |
|
TARSUS PHARMACEUTICALS, INC. | 0.8% |
IHE Underweight Relative to FTXH
|
ABBVIE INC | -7.4% |
|
AMGEN INC | -3.7% |
|
BIOGEN IDEC INC | -3.7% |
|
GILEAD SCIENCES INC | -3.7% |
|
UNITED THERAPEUTICS CORP | -3.6% |
|
REGENERON PHARMACEUTICALS | -3.4% |
|
BRISTOL-MYERS SQUIBB CO | -3.0% |
|
MERCK & CO. INC. | -2.9% |
|
PFIZER INC | -2.7% |
|
CHARLES RIVER LABORATORIES | -2.0% |